Outcome following intracranial hemorrhage associated with novel oral anticoagulants
- 1 January 2015
- journal article
- case report
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 22 (1), 212-215
- https://doi.org/10.1016/j.jocn.2014.04.025
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Intracerebral HemorrhageNeurosurgery Clinics of North America, 2013
- Dabigatran, intracranial hemorrhage, and the neurosurgeonNeurosurgical Focus, 2013
- Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation ReversalStroke, 2012
- Anti-stroke prophylaxis – the ethics of collateral damageJournal of Clinical Neuroscience, 2012
- How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switchBlood, 2012
- Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulationJournal of Internal Medicine, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Warfarin, hematoma expansion, and outcome of intracerebral hemorrhageNeurology, 2004